Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia

Journal of Endovascular Therapy

Volumn 18, Issue 1, 2011, Pages 1-12

  Karnabatidis, Dimitris ^a   Spiliopoulos, Stavros ^a   Diamantopoulos, Athanasios ^a   Katsanos, Konstantinos ^a   Kagadis, George C ^a   Kakkos, Stavros ^a   Siablis, Dimitris ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS;

ADULT; AGED; ARTERY DISEASE; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; DRUG ELUTING STENT; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECANALIZATION; RESTENOSIS; REVASCULARIZATION; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; AMPUTATION; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; CARDIOVASCULAR AGENTS; CONSTRICTION, PATHOLOGIC; CRITICAL ILLNESS; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; GREECE; HUMANS; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LOWER EXTREMITY; MALE; METALS; MIDDLE AGED; POPLITEAL ARTERY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 79951787896     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/10-3242.1     Document Type: Article

References (37)

1. Conrad MF, Kang J, Cambria RP, et al. Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease. J Vasc Surg. 2009;50:799-805 e4.
2. Romiti M, Albers M, Brochado-Neto FC, et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008;47:975-981.
3. Albers M, Romiti M, Brochado-Neto FC, et al. Meta-analysis of alternate autologous vein bypass grafts to infrapopliteal arteries. J Vasc Surg. 2005;42:449-455.
4. Commeau P. Endovascular procedures for below the knee arteries in diabetics. Ann Cardiol Angiol (Paris). 2008;57:352-358.
5. Tsetis D, Belli AM. The role of infrapopliteal angioplasty. Br J Radiol. 2004;77:1007-1015. (Pubitemid 40057797)
6. Kuusela J, Manninen HI, Karhapaa P. Infrapopliteal balloon angioplasty for chronic critical limb ischemia in diabetic patients with uremia: when is it worth the effort? J Vasc Interv Radiol. 2009;20:342-346.
7. Faglia E, Mantero M, Caminiti M, et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med. 2002;252:225-232.
8. Soder HK, Manninen HI, Jaakkola P, et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol. 2000;11:1021-1031.
9. Qureshi AI, Kirmani JF, Hussein HM, et al. Early and intermediate-term outcomes with drugeluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery. 2006;59:1044-1051. (Pubitemid 44852090)
10. Zahringer M, Pattynama PM, Talen A, et al. Drug-eluting stents in renal artery stenosis. Eur Radiol. 2008;18:678-82. (Pubitemid 351447772)
11. Duda SH, Bosiers M, Lammer J, et al. Drugeluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13:701-710. (Pubitemid 44907633)
12. Siablis D, Karnabatidis D, Katsanos K, et al. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol. 2009;20:1141-1150.
13. Grant AG, White CJ, Collins TJ, et al. Infrapopliteal drug-eluting stents for chronic limb ischemia. Catheter Cardiovasc Interv. 2008;71:108-111. (Pubitemid 351158354)
14. Siablis D, Karnabatidis D, Katsanos KD, et al. Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: midterm angiographic and clinical results. J Vasc Interv Radiol. 2007;18:1351-1361. (Pubitemid 350010920)
15. Siablis D, Karnabatidis D, Katsanos K, et al. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit. J Endovasc Ther. 2007;14:241-250. (Pubitemid 46776123)
16. Scheinert D, Ulrich M, Scheinert S, et al. Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions. EuroIntervention. 2006;2:169-174.
17. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol. 2004;44:2307-2314. (Pubitemid 39647603)
18. Popma JJ, Topol EJ. Factors influencing restenosis after coronary angioplasty. Am J Med. 1990;88(1N):16N-24N.
19. De Luca G, Suryapranata H, Timmer J, et al. Impact of routine stenting on clinical outcome in diabetic patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. Diabetes Care. 2006;29:920-923. (Pubitemid 44115317)
20. Commeau P, Barragan P, Roquebert PO. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheter Cardiovasc Interv. 2006;68:793-798. (Pubitemid 44721107)
21. Siablis D, Kraniotis P, Karnabatidis D, et al. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther. 2005;12:685-695. (Pubitemid 43100926)
22. Sacks D, Marinelli DL, Martin LG, et al. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. J Vasc Interv Radiol. 2003;14(9 Pt 2):S395-404.
23. Palmaz JC. The balloon-expandable stent. EuroIntervention. 2007;2:416-421.
24. Palmaz JC. Bring that pioneering spirit back! A 25-year perspective on the vascular stent. Cardiovasc Intervent Radiol. 2007;30:1095-1098. (Pubitemid 350059836)
25. Karas SP, Santoian EC, Gravanis MB. Restenosis following coronary angioplasty. Clin Cardiol. 1991;14:791-801.
26. Vaitkus PT. Effect of stents in reducing restenosis in small coronary arteries: a metaanalysis. Catheter Cardiovasc Interv. 2004;62:425-429. (Pubitemid 39045282)
27. Biondi-Zoccai GG, Sangiorgi G, Lotrionte M, et al. Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther. 2009;16:251-260.
28. Feiring AJ, Krahn M, Nelson L, et al. Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol. 2010;55:1580-1589.
29. Rastan A, Schwarzwälder U, Noory E, et al. Primary use of sirolimus-eluting stents in the infrapopliteal arteries. J Endovasc Ther. 2010;17:480-487.
30. Garg S, Serruys P, Onuma Y, et al. 3-year clinical follow-up of the XIENCE V everolimuseluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2009;2:1190-1198.
31. Stone GW, Midei M, Newman W, et al. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Circulation. 2009;119:680-686.
32. Serruys PW, Ruygrok P, Neuzner J, et al. A randomised comparison of an everolimuseluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial. EuroIntervention. 2006;2:286-294.
33. Serruys PW, Ong AT, Piek JJ, et al. A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: the SPIRIT first trial. EuroIntervention. 2005;1:58-65.
34. Davies MG, Saad WE, Peden EK, et al. Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss. J Vasc Surg. 2008;48:619-626.
35. Davies MG, Saad WE, Peden EK, et al. Percutaneous superficial femoral artery interventions for claudication - does runoff matter? Ann Vasc Surg. 2008;22:790-798.
36. Salapura V, Blinc A, Kozak M, et al. Infrapopliteal run-off and the outcome of femoropopliteal percutaneous transluminal angioplasty. Vasa. 2010;39:159-168.
37. Peregrin JH, Koznar B, Kovac J, et al. PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc Intervent Radiol. 2010;33:720-725.